Cipher Pharmaceuticals Inc (CPHRF)
6.61
-0.04
(-0.60%)
USD |
OTCM |
May 09, 15:10
Cipher Pharmaceuticals Price: 6.61 for May 9, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 08, 2024 | 6.68 | 6.69 | 6.56 | 6.65 | 4453.00 |
May 07, 2024 | 6.84 | 6.90 | 6.75 | 6.75 | 6000.00 |
May 06, 2024 | 6.60 | 6.82 | 6.51 | 6.81 | 17344.00 |
May 03, 2024 | 6.494 | 6.63 | 6.494 | 6.60 | 11808.00 |
May 02, 2024 | 6.30 | 6.53 | 6.30 | 6.53 | 1441.00 |
May 01, 2024 | 6.30 | 6.30 | 6.25 | 6.25 | 2975.00 |
Apr 30, 2024 | 6.248 | 6.36 | 6.248 | 6.30 | 3752.00 |
Apr 29, 2024 | 6.22 | 6.27 | 6.21 | 6.24 | 1849.00 |
Apr 26, 2024 | 6.27 | 6.27 | 6.23 | 6.23 | 2044.00 |
Apr 25, 2024 | 6.15 | 6.27 | 6.15 | 6.26 | 12506.00 |
Apr 24, 2024 | 6.23 | 6.295 | 6.23 | 6.23 | 4600.00 |
Apr 23, 2024 | 6.43 | 6.70 | 6.43 | 6.50 | 22273.00 |
Apr 22, 2024 | 5.76 | 6.22 | 5.76 | 6.22 | 11509.00 |
Apr 19, 2024 | 6.342 | 6.342 | 6.18 | 6.20 | 14585.00 |
Apr 18, 2024 | 6.29 | 6.354 | 6.29 | 6.354 | 3544.00 |
Apr 17, 2024 | 6.50 | 6.50 | 6.41 | 6.41 | 3095.00 |
Apr 16, 2024 | 6.53 | 6.60 | 6.48 | 6.48 | 4588.00 |
Apr 15, 2024 | 6.85 | 6.93 | 6.71 | 6.79 | 16785.00 |
Apr 12, 2024 | 6.85 | 6.85 | 6.70 | 6.78 | 10177.00 |
Apr 11, 2024 | 6.00 | 6.66 | 6.00 | 6.65 | 15291.00 |
Apr 10, 2024 | 6.10 | 6.14 | 6.07 | 6.135 | 7840.00 |
Apr 09, 2024 | 6.25 | 6.29 | 6.154 | 6.18 | 38601.00 |
Apr 08, 2024 | 6.282 | 6.30 | 6.15 | 6.15 | 16241.00 |
Apr 05, 2024 | 6.20 | 6.225 | 6.15 | 6.15 | 7484.00 |
Apr 04, 2024 | 6.63 | 6.63 | 6.37 | 6.37 | 4928.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.3028
Minimum
Mar 23 2020
7.16
Maximum
Mar 26 2024
1.929
Average
1.524
Median
Mar 10 2022
Price Benchmarks
Acasti Pharma Inc | 2.77 |
Aurinia Pharmaceuticals Inc | 5.175 |
Edesa Biotech Inc | 4.52 |
Lexaria Bioscience Corp | 3.58 |
Xenon Pharmaceuticals Inc | 42.44 |
Price Related Metrics
PE Ratio | 8.367 |
PS Ratio | 7.946 |
Price to Book Value | 1.979 |
Price to Free Cash Flow | 10.51 |
Earnings Yield | 11.95% |
Market Cap | 159.35M |
Operating PE Ratio | 16.76 |
Normalized PE Ratio | 8.644 |